Recently India has stopped using COVID-19 test kits which are supplied from China. Over this, China has expressed deep concern and on Tuesday it said that their products do meet quality standards and not only India, but these test kits are exported to many other countries as well.
On Tuesday, Ji Rong, spokesperson of the Chinese embassy said in a statement that China gives priority to the quality of medical products they are exporting and it is not fair and irresponsible for certain individuals to label Chinese products as ‘faulty’ and look at issues with pre-emptive prejudice.
China stated this statement hours after the Indian Council of Medical Research (ICMR), which plays a key role in advising authorities engaged in the fight against Covid-19, said that the government of each state should stop using the rapid antibody testing kits from two Chinese producers, Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics after several states questioned the efficacy of the kits.
Ji said that they are deeply concerned with the evaluation results and the decision made by ICMR.
She further said that both Wondfo and Livzon had clarified that their kits are certified to be used as they meet the quality standards, by China’s National Medical Products Administration (NMPA), and had also been validated and approved by ICMR through the National Institute of Virology (NIV) in Pune.
She further added that the Covid-19 antibody rapid test kits produced by these two Chinese companies have been exported to and well recognized in many countries in Europe, Asia, and Latin America.
Ji further said that Beijing is in hopes that New Delhi could regard China’s goodwill and reliability, strengthen communication timely with appropriate Chinese companies based on facts, and resolve [the matter] reasonably and properly.
The embassy spokesperson said they hope that India would respect “China’s goodwill and sincerity, strengthen communication timely with relevant Chinese companies based on facts, and resolve it reasonably and properly.”
Several states have made a complaint about the new test kits, saying that they had only 5.4 percent accuracy. Opposition parties are also questioning the government’s purchase.